Inflammatory reaction and its importance in the course of tumour process

Czech version

Authors: D. Hlávková ¹; O. Kopecký ^2,3; Š. Lukešová ^2,3
Authors‘ workplace: Ústav klinické imunologi e a alergologi e Lékařské fakulty UK a FN Hradec Králové, přednosta prof. RNDr. Jan Krejsek, CSc. ¹; Oddělení klinické imunologi e a alergologi e Oblastní nemocnice Náchod, a. s., přednosta doc. MUDr. Otakar Kopecký, CSc. ²; II. interní klinika Lékařské fakulty UK a FN Hradec Králové, přednosta prof. MUDr. Jaroslav Malý, CSc. ³
Published in: Vnitř Lék 2008; 54(9): 821-826
Category: Review

Overview

This article gives basic informati on abo ut the formati on and the co urse of the inflammatory re acti on, which is the important adaptati on mechanism of the organism on the vari o us external and internal injurants. The main attenti on is fixated on the role of the immune system in the co urse of the inflammatory re acti on. It de als with the presence and the sense of the inflammatory re acti on in the tumo ur environment in more detail. It gives the short informati on abo ut the mechanisms of the antitumo ur defence. The influence of the inflammatory re acti on on the genesis, the co urse and the progressi on of the tumo ur dise ase is discussed in the third chapter.

Key words:
inflammatory re acti on – immune system – antitumo ur imunity – tumo ur microenvironment – cytokines – chemokines

Sources

1. Gabay C, Kushner I. Acute-phase proteins and other systemic response to inflammati on. N Engl J Med 1999; 340: 448– 454.

2. Krejsek J, Kopecký O. Klinická imunologi e. Hradec Králové: Nucle us HK 2004: 385– 405, 541– 566.

3. Co ussens LM, Werb Z. Inflammati on and cancer. Nature 2002; 420: 860– 867.

4. Scimone ML, Lutzky VP, Zittermann SI et al. Migrati on of polymorphonucle ar le ucocytes is influenced by dendritic cells. Immunology 2005; 114: 375– 385.

5. Banchere a u J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245– 252.

6. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14: 129– 135.

7. Sozzani S, Allavena P, Vecchi A et al. Chemokines and dendritic cell traffic. J Clin Immunol 2000; 20: 151– 160.

8. Adema GJ, Hartgers F, Verstraten R et al. A dendritic- cell- derived C- C chemokine that preferenti ally attracts naive T cells. Nature 1997; 387: 713– 717.

9. Sallusto F, Lenig D, Mackay CR et al. Flexible programs of chemokine receptor expressi on on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875– 883.

10. Tang HL, Cyster JG. Chemokine Up- regulati on and activated T cell attracti on by maturing dendritic cells. Sci ence 1999; 284: 819– 822.

11. Zijlstra A, Se andel M, Kupriyanova TA et al. Pro angi ogenic role of ne utrophil‑like inflammatory heterophils during neovascularizati on induced by growth factors and human tumor cells. Blo od 2006; 107: 317– 327.

12. Vaday GG, Lider O. Extracellular matrix mo i eti es, cytokines, and enzymes: dynamic effects on immune cell behavi or and inflammati on. J Le ukoc Bi ol 2000; 67: 149– 159.

13. Distler JW, Hirth A, Kurowska- Stolarska M et al. Angi ogenic and angi ostatic factors in the molecular control of angi ogenesis. Q J Nucl Med 2003; 47: 149– 161.

14. Belperi o JA, Ke ane MP, Arenberg DA et al. CXC chemokines in angi ogenesis. J Le ukoc Bi ol 2000; 68: 1– 8.

15. Klener P. Klinická onkologi e. Praha: Galén 2002: 223– 230.

16. Hoeijmakers JHJ. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366– 374.

17. Soloski MJ. Recogniti on of tumor cells by the innate immune system. Curr Opin Immunol 2001; 13: 154– 162.

18. Ca ux C, Li u YJ, Banchere a u J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995; 16: 2– 4.

19. Pardoll DM, Topali an SL. The role of CD4+ T cell responses in antitumor immunity. Curr Opin Immunol 1998; 10: 588– 594.

20. Moretta A, Bottino C, Vitale M et al. Receptors for HLA class- I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619– 648.

21. Kos FJ. Regulati on of adaptive immunity by natural killer cells. Immunol Res 1998; 17: 303– 312.

22. Bukowski RM, Rayman P, Molto L et al. Interferon- γ and CXC chemokine inducti on by interle ukin 12 in renal cell carcinoma. Clin Cancer Res 1999; 5: 2780– 2789.

23. Tsung K, Dolan JP, Tsung YL et al. Macrophages as effector cells in interle ukin 12‑induced T cell-dependent tumor rejecti on. Cancer Res 2002; 62: 5069– 5075.

24. Lukešová Š, Kopecký O. Protinádorová imunitní odpověď. Alergi e 2007; 3: 241– 244.

25. Wang JM, Su S, Gong W et al. Chemokines, receptors, and their role in cardi ovascular pathology. Int J Clin Lab Res 1998; 28: 83– 90.

26. Hofseth LJ, Wargovich MJ. Inflammati on, cancer and targets of ginseng. J Nutr 2007; 137(Suppl 1): 183S– 185S.

27. O’Byrne KJ, Dalgleish AG. Chronic immune activati on and inflammati on as the ca use of malignancy. Br J Cancer 2001; 85: 473– 483.

28. Balkwill F, Mantovani A. Inflammati on and cancer: back to Virchow? Lancet 2001; 357: 539– 545.

29. Kuper H, Adami HO, Trichopo ulos D. In-fecti ons as a major preventable ca use of human cancer. J Intern Med 2000; 248: 171– 183.

30. Wang JM, Deng X, Gong W et al. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998; 220: 1– 17.

31. Schoppman SF, Birner P, Stöckl J et al. Tumor- associ ated macrophages express lymphatic endotheli al growth factors and are related to peritumoral lymphangi ogenesis. Am J Pathol 2002; 16: 947– 956.

32. Mudroch C, Finn A. Chemokine receptors and their role in inflammati on and infecti o us dise ases. Blo od 2000; 95: 3032– 3043.

33. O’Byrne KJ, Dalgleish AG, Browning MJ et al. The relati onship between angi ogenesis and the immune response in carcinogenesis and the progressi on of malignant dise ase. Eur J Cancer 2000; 36: 151– 169.

34. Raman D, Ba ugher PJ, Thu YM et al. Role of chemokines in tumor growth. Cancer Lett 2007; 256: 137– 165.